Advertisement
News
Subscribe to MDT Magazine News

Federal Register: General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting; Meeting on November 18, 2010

August 16, 2010 5:30 am | Comments

This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public. Name of Committee: General and Plastic Surgery Devices Panel of the Medical Devices Advisory...

Mednax buys another practice, its eighth this year

August 16, 2010 4:45 am | by The Associated Press | Comments

Mednax has added a pediatric cardiology practice to its growing list of services, the national physician's group said Monday.Terms were not disclosed.The practice includes two doctors who provide cardiology services to pediatric patients throughout southern Texas where it is based. The doctors...

Rising Burden of Diseases Drives the Pharmaceutical Industry in East Africa, Says Frost & Sullivan

August 16, 2010 2:32 am | by Bio-Medicine.Org | Comments

CAPE TOWN, South Africa, Aug. 16 /- Infectious diseases are rampant in sub-Saharan Africa. Urbanisation and westernised lifestyles have further increased the prevalence of non-communicable diseases such as cancer. The strong correlation between infectious diseases and cancer has...

TOPICS:
Advertisement

Heartbeats at the Speed of Light

August 15, 2010 10:32 pm | by Massachusetts Institute of Technology | Comments

Laser pulses can control a beating heart without causing damage, and could lead to new kinds of pacemakers.

TOPICS:

Drugs encased in nanoparticles travel to tumors on the surface of immune-system cells

August 15, 2010 11:31 am | by EurekAlert | Comments

(Massachusetts Institute of Technology) Now a team of MIT engineers has devised a way to deliver the necessary drugs by smuggling them on the backs of the cells sent in to fight the tumor. That way, the drugs reach only their intended targets, greatly reducing the risk to the patient.

TOPICS:

New Supercomputer Connection Speeds Genetic Research

August 15, 2010 2:33 am | by Bio-Medicine.Org | Comments

PHOENIX, Aug. 13 /- A Cox Business light-speed computer connection coupled with advanced, military-grade technology now provides Translational Genomics Research Institute (TGen) with the nation's fastest supercomputer link among life-sciences facilities. This enhanced capability moves...

TOPICS:

CeNeRx BioPharma Completes $13 Million Series C Financing

August 14, 2010 12:33 am | by Bio-Medicine.Org | Comments

RESEARCH TRIANGLE PARK, N.C., Aug. 13 /- CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system (CNS), today announced completion of a $13 million Series C financing.  Existing investors Perseus...

TOPICS:

Frost & Sullivan: Innovative Products and Technologies Strengthen U.S. Spinal Surgery Market

August 13, 2010 9:32 pm | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif., Aug. 12 /- As more and more patients become aware of the advantages of the advanced non-fusion spinal surgery techniques, the negatives of the spinal fusion market become more obvious to the end users. In the next five years, the industry expects to see a steady...

TOPICS:
Advertisement

Chula Vista's Dr. Peter Rullan Adds Alma Lasers' Pixel CO2 Laser System to Offer Fractional CO2 Laser Treatments to Patients

August 13, 2010 9:32 pm | by Bio-Medicine.Org | Comments

CHULA VISTA, Calif., Aug. 12 /- Founder of the Dermatology Institute, Peter Rullan, M.D., has expanded his practice and is now offering Pixel Perfect™ treatments to his patients with the purchase of the Pixel CO2 laser from Alma Lasers. "I'm very excited to add this new service for...

TOPICS:

NewCardio Announces Financial Results for the First Half of 2010 and Commercialization Progress

August 13, 2010 9:31 pm | by Bio-Medicine.Org | Comments

SANTA CLARA, Calif., Aug. 12 /- NewCardio, Inc., (OTC Bulletin Board: http://www.newcardio.com . Select questions for the conference call will also be taken via email at nwci@haydenir.com and can be sent any time prior to the conference call's starting time. A replay of the call will be...

TOPICS:

Expanding Access to Care in Chicago's Englewood Neighborhood

August 13, 2010 8:31 pm | by Baxter | Comments

More than 40 million Americans lack adequate health insurance. This includes an estimated 1.3 million in the Chicago area, where Baxter International Inc. is headquartered. As a leading healthcare company, Baxter is committed to increasing access to healthcare around the world through both its bu

TOPICS:

Estrogen not associated with lung cancer incidence and mortality among postmenopausal women

August 13, 2010 2:31 pm | by EurekAlert | Comments

(Journal of the National Cancer Institute) Use of estrogen alone did not increase lung cancer mortality in postmenopausal women, according to a study published online Aug. 13 in the Journal of the National Cancer Institute.

TOPICS:

Biotech vet Chip Clark takes CBO role at Genocea Biosciences

August 13, 2010 1:34 pm | by Mass High Tech: The Journal of New England Technology | Comments

Genocea Biosciences has named Chip Clark, co-founder of Maryland biotech Vanda Pharmaceutical Inc., as chief business officer of the vaccine-focused biotech firm in Cambridge.

Federal Register: Medical Device User Fee Act; Public Meeting; Request for Comments; Meeting on September 14, 2010

August 13, 2010 1:34 pm | by U.S. Food & Drug Administration | Comments

The FDA is announcing a public meeting on the reauthorization of the medical device user fee program. The current legislative authority for the medical device user fee program expires in September 2012 and new legislation will be required for FDA to...

TOPICS:

MMRC joins UK biotech in start of multiple myeloma trial

August 13, 2010 1:34 pm | by Mass High Tech: The Journal of New England Technology | Comments

A Phase 2 clinical trial of a treatment for relapsed or refractory multiple myeloma has launched, led by U.K.-based Astex Therapeutics Ltd. and funded by Norwalk, Conn.-based Multiple Myeloma Research Consortium (MMRC).

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading